Fast Five Quiz: Duchenne Muscular Dystrophy Management

Jasvinder P. Chawla, MD, MBA


May 30, 2023

Duchenne muscular dystrophy (MD) is a severe MD characterized by muscle degeneration and necrosis. It is caused by a lack of the protein dystrophin within muscles, making the muscles more sensitive to damage and limiting muscle repair mechanisms. This disorder results in the progressive loss of muscle tissue and function. Young patients with Duchenne MD retain muscle function to ambulate, but muscle function deteriorates through childhood, and the patient loses mobility between 10 and 12 years of age. Cardiomyopathy develops late in the disease course. The prognosis is poor for patients with Duchenne MD. A multidisciplinary medical, surgical, and rehabilitative approach to managing the symptoms of Duchenne MD can alter the timeline of the disease course, and improvements in treatments for cardiopulmonary dysfunction over the past 50 years have extended median survival from 25 to 40 years for patients who receive optimal care.

How well do you know about the management of Duchenne MD? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.